VintaBio, a biotech manufacturer specializing in high-yield, high-purity viral vectors for gene therapy, today presented data further demonstrating the advantages and productivity of its proprietary ...

Gene therapy is at the cutting edge of medicine, with exciting new products being developed and used to treat a wide variety ...

Mass photometry enables rapid, purification-free quantification of rAAV vectors, offering a faster solution for gene therapy ...

Bristol Myers Squibb plans to close its viral vector production facility in Libertyville, IL according to a BMS spokesperson ...

PackGene Biotech, Inc. announced today six presentations at the American Society of Gene & Cell Therapy (ASGCT) 28th annual meeting in New Orleans, May 13-17, highlighting the company's comprehensive ...

Cell and gene therapies offer potential new therapeutics but are currently constrained by complex and inefficient manufacturing strategies.

demonstrate that VintaProcess™ enables enrichment of full capsids at harvest by extending viral vector production using a novel perfusion process, offering a major step forward in simplifying ...

AnelloBricks is a promising in vitro approach to producing a new class of functional viral vectors, offering dramatic advantages in manufacturing scalability and cost compared to ...